Novavax, Inc. (NVAX) Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season. Zacks.com users have recently been ... 06/12/2024 - 5:00 am | View Link
Better Buy: Inovio Pharmaceuticals vs. Novavax Novavax just signed a lucrative agreement with a biotech giant. Inovio Pharmaceuticals is inching closer to launching its leading candidate. Both companies look risky, but one has a clear edge ... 05/21/2024 - 10:44 pm | View Link
Novavax Shares Pop Another 50% Following Sanofi Deal Shares of Novavax continued their ascent on Monday, adding to gains from last week after the company announced a licensing deal with Sanofi. The stock was up 50% to $13.31 in afternoon trading ... 05/13/2024 - 10:33 am | View Link
Novavax shares soar on license deal with Sanofi at lofty valuation (Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm at ... 05/13/2024 - 1:38 am | View Link
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi Shares of Novavax surged after the company disclosed a $1.4 billion licensing deal with Sanofi. The stock was up 72% at $7.66 in premarket trading on Friday. Shares are on track to open in ... 05/9/2024 - 11:44 pm | View Link